Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2049 - 2056 of 12086 results

Newly Enacted Federal “Speak Out Act” Limits Use of Some Sexual Harassment NDAs
December 9, 2022| Blog| Viewpoint

Partnering and Giving Back With Clinic in a Box®
December 8, 2022| Article| Viewpoint

From the Edge - In the Boardroom: Session 6 - Crises in the Boardroom
December 7, 2022| Podcast| Viewpoint

MintzTech Connect: All Things Technology — December 2022
December 7, 2022| Article| Viewpoint

MintzTech Connect Industry News: Spotlight on Ben Zises and SuperAngel.Fund
December 7, 2022| Article| Viewpoint

Is Your Website Collecting PHI Under OCR's New Tracking Technologies Bulletin?
December 7, 2022| Blog| Viewpoint

Preparation for 2022 Fiscal Year-End SEC Filings and 2023 Annual Shareholder Meetings
December 7, 2022| Advisory| Viewpoint

No Uncertain Terms - What 2023 Has in Store for M&A Activity, Valuations and Deal Terms
December 7, 2022| News
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
